We address the real-world problem of automating the design of high-quality prostate cancer treatment plans in case of high-dose-rate brachytherapy, a form of internal radiotherapy. For this, recently a bi-objective real-valued problem formulation was introduced. With a GPU parallelization of the Multi-Objective Real-Valued Gene-pool Optimal Mixing Evolutionary Algorithm (MO-RV-GOMEA), good treatment plans were found in clinically acceptable running times. However, optimizing a treatment plan and delivering it to the patient in practice is a two-stage decision process and involves a number of uncertainties. Firstly, there is uncertainty in the identified organ boundaries due to the limited resolution of the medical images. Secondly, the treatment involves placing catheters inside the patient, which always end up (slightly) different from what was optimized. An important factor is therefore the robustness of the final treatment plan to these uncertainties. In this work, we show how we can extend the evolutionary optimization approach to find robust plans using multiple scenarios without linearly increasing the amount of required computation effort, as well as how to deal with these uncertainties efficiently when taking into account the sequential decision-making moments. The performance is tested on three real-world patient cases. We find that MO-RV-GOMEA is equally well capable of solving the more complex robust problem formulation, resulting in a more realistic reflection of the treatment plan qualities.

, , , ,
doi.org/10.1007/978-3-030-58115-2_31
Lecture Notes in Computer Science/Lecture Notes in Artificial Intelligence
16th International Conference, PPSN 2020, Leiden, The Netherlands, September 5-9, 2020

van der Meer, M., Bel, A., Niatsetski, Y., Alderliesten, T., Pieters, B., & Bosman, P. (2020). Robust evolutionary bi-objective optimization for prostate cancer treatment with high-dose-rate brachytherapy. In International Conference on Parallel Problem Solving from Nature, PPSN 2020 (pp. 441–453). doi:10.1007/978-3-030-58115-2_31